Aetna 2009 Annual Report Download - page 79

Download and view the complete annual report

Please find page 79 of the 2009 Aetna annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 100

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100

During 2009, 2008 and 2007, the following activity occurred under the Plans:
(Millions) 2009 2008 2007
Cash received from stock option exercises 14.9$ 29.7$ 163.1$
Intrinsic value (the excess of market price on the date of exercise over the exercise price) 46.9 75.5 494.1
Tax benefits realized for the tax deductions from stock options and SARs exercised 16.4 26.4 172.9
Fair value of stock options, SARs and stock units vested 98.7 86.5 18.0
We settle stock options with newly-issued common stock and generally utilize the proceeds to repurchase common
stock in the open market in the same period.
The following is a summary of information regarding stock options and SARs outstanding and exercisable at
December 31, 2009 (number of stock options and SARs and aggregate intrinsic values in millions):
Weighted
Average Weighted Weighted
Remaining Average Aggregate Average Aggregate
Number Contractual Exercise Intrinsic Number Exercise Intrinsic
Range of Exercise Prices Outstanding Life (Years) Price Value Exercisable Price Value
$0.00-$10.00 5.9 1.5 8.38$ 136.0$ 5.9 8.38$ 136.0$
10.00-20.00 12.7 3.0 14.55 218.0 12.7 14.55 218.1
20.00-30.00 .3 8.6 23.37 2.6 .1 22.25 .9
30.00-40.00 11.6 6.2 32.93 - 6.5 33.57 -
40.00-50.00 5.0 6.7 43.21 - 3.5 43.17 -
50.00-60.00 8.6 6.1 50.46 - 5.9 50.35 -
$0.00-$60.00 44.1 4.7 28.88$ 356.6$ 34.6 26.16$ 355.0$
Outstanding Exercisable
RSU and PSU transactions in 2009, 2008 and 2007 were as follows (number of units in millions):
Weighted Weighted Weighted
Average Average Average
RSUs
and PSUs
Grant Date
Fair Value
RSUs
and PSUs
Grant Date
Fair Value RSUs
Grant Date
Fair Value
RSUs and PSUs at beginning of year
(1)
2.4 42.98$ 1.4 46.15$ .8 49.52$
Granted 1.8 30.27 1.5 39.81 .8 43.15
Vested (1.1) 45.11 (.4) 44.78 (.1) 47.70
Forfeited -
(2)
38.56 (.1) 45.74 (.1) 46.36
RSUs and PSUs at end of year 3.1 34.60$ 2.4 42.98$ 1.4 46.15$
2009 2008 2007
(1) There were no PSU transactions prior to February, 2008.
(2) Rounds to zero.
In 2009, 2008 and 2007 we recorded pretax share-based compensation expense of $91 million, $96 million and $89
million, respectively, in general and administrative expenses. We also recorded related tax benefits of $32 million,
$34 million and $32 million in 2009, 2008 and 2007, respectively. At December 31, 2009, $95 million of total
unrecognized compensation costs related to stock options, SARs, RSUs and PSUs is expected to be recognized over a
weighted-average period of 1.7 years.
Annual Report – Page 73